Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis - 2020 update.
Fernandes BM, Guimarães F, Almeida DE, Neto A, Tavares-Costa J, Ribeiro AR, Quintal A, Pereira JP, Silva L, Nóvoa TSD, Faustino A, Vaz C, Khmelinskii N, Samões B, Dourado E, Silva JL, Barcelos A, Mariz E, Guerra M, Santos MJ, Silvério-António M, Teixeira RL, Romão VC, Santos H, Santos-Faria D, Azevedo S, Rodrigues A, Dias JM, Lopes C, Pinto P, Couto M, Miranda LC, Bernardo A, Cruz M, Teixeira F, Mourão AF, Neto A, Teixeira V, Cordeiro A, Barreira S, Inês LS, Capela S, Sepriano A, Canhão H, Fonseca JE, Duarte C, Bernardes M.
Fernandes BM, et al. Among authors: almeida de.
ARP Rheumatol. 2022 Jan-Mar;1(1):63-82.
ARP Rheumatol. 2022.
PMID: 35633578
Free article.
English.